Cara Therapeutics: Q2 Earnings Insights

Cara Therapeutics: Q2 Earnings Insights


Cara Therapeutics CARA reported its Q2 earnings results on Monday, August 8, 2022 at 04:01 PM.

Here's what investors need to know about the announcement.


Cara Therapeutics beat estimated earnings by 68.0%, reporting an EPS of $-0.08 versus an estimate of $-0.25.

Revenue was up $23.00 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.02 which was followed by a 23.76% increase in the share price the next day.

Here's a look at Cara Therapeutics's past performance:


Quarter Q1 2022 Q4 2021 Q3 2021 Q2 2021
EPS Estimate -0.54 -0.52 -0.40 -0.53
EPS Actual -0.52 -0.63 -0.02 -0.61
Revenue Estimate 3.16M 1.46M 11.21M 2.36M
Revenue Actual 4.79M 821K 20.27M 0

To track all earnings releases for Cara Therapeutics visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: BZI-RecapsEarningsNews